Study
BEACON is Omnia's flagship longitudinal patient experience study focused on people using GLP-1 therapies.
Through IRB-approved research and ongoing patient engagement, BEACON generates real-world evidence on treatment persistence, quality of life, daily functioning, behavioral trends, and the evolving experience of GLP-1 care.
Access
Insights
BEACON is designed to be more than a longitudinal study—it's a patient intelligence platform. Organizations can access longitudinal real-world insights across the GLP-1 journey, while launching targeted nested studies that explore specific therapies, populations, outcomes, and unmet needs.
Medicare GLP-1 Bridge Program
The Medicare GLP-1 Bridge Program is a dedicated BEACON research initiative focused on understanding the experiences of individuals enrolled in the Medicare Bridge Program.
Through ongoing patient-reported data collection, BEACON captures information on activities of daily living, mobility, independence, and other functional outcomes that are particularly relevant to the Medicare population.
